AMLX · Company research
Amylyx Pharmaceuticals, Inc. (AMLX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? - Stocktwits | Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| Dow, S&P 500, Nasdaq Futures Slip As Global Bond Rout Catches Up With Markets: LUNR, MSTR, WYFI, AMLX Stocks In Focus - Stocktwits | Dow, S&P 500, Nasdaq Futures Slip As Global Bond Rout Catches Up With Markets: LUNR, MSTR, WYFI, AMLX Stocks In Focus Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| Amylyx Pharmaceuticals (NasdaqGS:AMLX) Stock Forecast & Analyst Predictions - Simply Wall Street | Amylyx Pharmaceuticals (NasdaqGS:AMLX) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 8, 2026 | neutral | 0 | 0.6 |
| Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? - Stocktwits | Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Under a preset trading plan, Amylyx Pharmaceuticals (AMLX) director sells 30,000 shares. - Stock Titan | Under a preset trading plan, Amylyx Pharmaceuticals (AMLX) director sells 30,000 shares. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Singapore | Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 7, 2026 | neutral | 0 | 0.6 |
| Blood-sugar drops after weight-loss surgery have no FDA-approved therapy. Amylyx will present trial results. - Stock Titan | Blood-sugar drops after weight-loss surgery have no FDA-approved therapy. Amylyx will present trial results. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| A director proposes selling 100,000 shares of Amylyx Pharmaceuticals (AMLX). - Stock Titan | A director proposes selling 100,000 shares of Amylyx Pharmaceuticals (AMLX). Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 5, 2026 | neutral | 0 | 0.6 |
| Amylyx Pharmaceuticals, Inc. (AMLX) Latest Stock News & Headlines - Yahoo! Finance Canada | Amylyx Pharmaceuticals, Inc. (AMLX) Latest Stock News & Headlines Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 4, 2026 | neutral | 0 | 0.6 |
| At 9:30 a.m. ET on Sept. 30, Amylyx management will present online. - Stock Titan | At 9:30 a.m. ET on Sept. 30, Amylyx management will present online. Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial - Barchart.com | AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial Barchart.com | View source ↗ | Barchart.com | Aug 18, 2026 | neutral | 0 | 0.6 |
| $AMLX stock is up 45% today. Here's what we see in our data. - Quiver Quantitative | $AMLX stock is up 45% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 18, 2026 | neutral | 0 | 0.6 |
| AMLX Stock Heads For Best Day In Nearly Four Years – Retail Sees Near 70% Upside Potential From Current Levels - Stocktwits | AMLX Stock Heads For Best Day In Nearly Four Years – Retail Sees Near 70% Upside Potential From Current Levels Stocktwits | View source ↗ | Stocktwits | Aug 18, 2026 | neutral | 0 | 0.6 |
| AMLX Stock Clocks Best Day Ever After Positive Trial Data, Launches $350M Offering - Yahoo Finance | AMLX Stock Clocks Best Day Ever After Positive Trial Data, Launches $350M Offering Yahoo Finance | View source ↗ | Yahoo Finance | Aug 18, 2026 | neutral | 0 | 0.6 |
| AMLX Stock Heads For Best Day In Nearly Four Years – Retail Sees Near 70% Upside Potential From Current Levels - TradingView | AMLX Stock Heads For Best Day In Nearly Four Years – Retail Sees Near 70% Upside Potential From Current Levels TradingView | View source ↗ | TradingView | Aug 18, 2026 | neutral | 0 | 0.6 |
| Why Is AMLX Stock Popping 14% After Hours? - Stocktwits | Why Is AMLX Stock Popping 14% After Hours? Stocktwits | View source ↗ | Stocktwits | Aug 17, 2026 | neutral | 0 | 0.6 |
| Amylyx Pharmaceuticals (AMLX) Stock Trades At A Premium After Avexitide Trial Progress - Yahoo Finance | Amylyx Pharmaceuticals (AMLX) Stock Trades At A Premium After Avexitide Trial Progress Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| Amylyx will discuss second-quarter results in Aug. 6 webcast - Stock Titan | Amylyx will discuss second-quarter results in Aug. 6 webcast Stock Titan | View source ↗ | Stock Titan | Aug 3, 2026 | neutral | 0 | 0.6 |
| Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data? - Yahoo Finance | Is Amylyx Pharmaceuticals, Inc. (AMLX) Stock Ready for a Breakout Ahead of Key LUCIDITY Trial Data? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.